Interleukin-22 Drives Endogenous Thymic Regeneration in Mice

Jarrod A. Dudakov(Memorial Sloan Kettering Cancer Center), Alan M. Hanash(Memorial Sloan Kettering Cancer Center), Robert R. Jenq(Memorial Sloan Kettering Cancer Center), Lauren Young(Memorial Sloan Kettering Cancer Center), Arnab Ghosh(Memorial Sloan Kettering Cancer Center), Natalie V. Singer(Memorial Sloan Kettering Cancer Center), Mallory L. West(Memorial Sloan Kettering Cancer Center), Odette M. Smith(Memorial Sloan Kettering Cancer Center), Amanda M. Holland(Memorial Sloan Kettering Cancer Center), Jennifer J. Tsai(Memorial Sloan Kettering Cancer Center), Richard L. Boyd(Monash Health), Marcel R.M. van den Brink(Memorial Sloan Kettering Cancer Center)
Science
March 3, 2012
Cited by 385Open Access
Full Text

Abstract

Endogenous thymic regeneration is a crucial function that allows for renewal of immune competence after stress, infection, or immunodepletion. However, the mechanisms governing this regeneration remain poorly understood. We detail such a mechanism, centered on interleukin-22 (IL-22) and triggered by the depletion of CD4(+)CD8(+) double-positive thymocytes. Intrathymic levels of IL-22 were increased after thymic insult, and thymic recovery was impaired in IL-22-deficient mice. IL-22, which signaled through thymic epithelial cells and promoted their proliferation and survival, was up-regulated by radio-resistant RORγ(t)(+)CCR6(+)NKp46(-) lymphoid tissue inducer cells after thymic injury in an IL-23-dependent manner. Administration of IL-22 enhanced thymic recovery after total body irradiation. These studies reveal mechanisms of endogenous thymic repair and offer innovative regenerative strategies for improving immune competence.


Related Papers

No related papers found

Powered by citation graph analysis